Financial Summary (All financials)
| In millions, except per share items | Feb-28-17 | Feb-29-16 | Feb-28-15 | Feb-28-14 |
| Revenues | 43.9 | 86.3 | 157.8 | 90.0 |
| Revenue growth | -49.1% | -45.3% | 75.3% | |
| Cost of goods sold | 37.6 | 81.2 | 132.8 | 79.3 |
| Gross profit | 6.3 | 5.1 | 24.9 | 10.7 |
| Gross margin | 14.4% | 5.9% | 15.8% | 11.8% |
| Sales and marketing | 7.4 | 10.6 | 14.0 | 13.2 |
| Research and development | 7.8 | 13.4 | 18.7 | 19.9 |
| General and administrative | 12.7 | 13.8 | 15.1 | 17.1 |
| EBITA | -13.2 | -49.0 | -16.3 | -31.8 |
| EBITA margin | -30.0% | -56.7% | -10.3% | -35.4% |
| Amortization of intangibles | 0.4 | 0.6 | 1.2 | 1.9 |
| EBIT | -13.6 | -49.5 | -17.5 | -33.7 |
| EBIT margin | -30.9% | -57.4% | -11.1% | -37.5% |
| Pre-tax income | -14.9 | -39.3 | -19.9 | -33.9 |
| Income taxes | 0.8 | 2.3 | 0.7 | 0.4 |
| Net income | -15.9 | -42.3 | -21.5 | -34.2 |
| Net margin | -36.2% | -49.0% | -13.6% | -38.0% |
| |
| Diluted EPS | ($3.26) | ($14.01) | ($7.90) | ($0.83) |
| Shares outstanding (diluted) | 4.9 | 3.0 | 2.7 | 41.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|